Chen Xia has a headache

Since he planned to take advantage of the popularity, he had already made preparations.

Just after Marite made his politically correct remarks at the press conference, Chen Xia also held his second press conference.

And at this press conference, Chen Xia found another ally, Swiss Novartis Pharmaceuticals, and the patent owner of cyclosporine.

Now the war of verbalism between the two sides is not just an academic dispute between the two sides, but has evolved into a "social phenomenon", triggering a wave of discussion among the whole nation.

After all, the price of medicine is high, and the difficulty of seeing a doctor is not only present in China, but also a big problem in European and American countries. Insurance companies, social welfare institutions, the National Health Insurance Administration, etc. are also having trouble.

Different interest groups are promoting this national discussion behind the scenes, and they all want to take the opportunity to win more support from the people.

Of course, the happiest thing is that the journalists all wrote articles and got the red envelopes.

Especially the red envelopes from Xiangjiang Pumpkin Vine Pharmaceutical Company are famous in the media circle for their richness, so there are more reporters coming to the second press conference.

At the press conference, Chen Xia showed huge anti-rejection drugs behind him. The names of the drugs on it were particularly large, which made people see at a glance.

Then Chen Xia stood in front of these drawing boards and gave the reporters what their effects, benefits and advantages they had.

"You can take a look at this medicine, such as this mycophenolate capsule, which is suitable for preventing organ rejection in patients undergoing allogeneic kidney or liver transplants. It is used simultaneously with cyclosporine A or tacrolimus and corticosteroids, and its efficacy is very certain."

The president of Novartis Pharmaceuticals on the stage smiled and nodded when he heard Chen Xia mention their drugs.

"Just like this, do you know how much the R&D cost of Xiangjiang Pumpkin Vine Pharmaceutical is?"

Chen Xia took out a thick stack of financial reports and threw them out:

"This drug has been studied by Huaguozhijiang Medical University for 7 years, and then continued to be studied by Pumpkin Vine Pharmaceuticals for 3 years, and it took almost $80 million to succeed.

Do you know what the offer price he gave to us when Professor Marit told me that when he wanted our patent, he only had US$10 million. But the R&D cost of my drug alone was US$80 million, which is not the currency conversion in recent years.

Don’t we have the only one medicine for mycophenolate, as well as tacrolimus, sirolimus, everolimus, rabbit anti-human T-lymphocyte immunoglobulin, etc.

The research and development of these drugs cost Pumpkin Vine Pharmaceutical a total of nearly US$500 million, which almost puts all the profits generated by the company over the years into it.

Do you think such patent transfer is fair? We are an enterprise, and all our R&D funds are our own. There is no government support, nor does it cost taxpayers a penny. They say that if you want a patent, you need a patent?

If it were all you here, would you agree? Professor Marit is clearly a robbery act!”

After saying that, Chen Xia waved his fist excitedly.

The flash of the reporter on the scene flashed into pieces, and the camera lens on the back also gave Chen Xia a close-up.

The names of the drugs behind Chen Xia were also passed on to thousands of households around the world, which were naturally free advertisements for showing their faces.

Now everyone knows what medicine has Pumpkin Vine invented, what its functions are, what is its cost, etc.

It is not so much a press conference as a disguised product conference.

Guens, president of Switzerland Novartis Pharmaceuticals, was also very angry. After Chen Xia finished speaking, he took the microphone.

"Professor Marit said that our production cost is only $1 per pill, but it costs $50. This is completely a distortion of concepts and misleading the public.

Is the cost of our drugs only the production cost? As Chen said just now, it costs 80 million US dollars for their development of a drug, which is in a region like China where prices and labor costs are lower.

Like ours in Switzerland, the cost is even higher. In order to develop cyclosporine, Novartis invested $150 million per one. Isn't this the cost of the drug? Shouldn't this be reflected in the drug price?

And everyone should note that we did not only develop one cyclosporine at the beginning, but also carried out as many as 10 drug developments at the same time, which cost more than 1 billion US dollars in total, and finally only succeeded one drug, so our real R&D cost should be 1 billion US dollars.

We would like to ask Professor Marit, as a famous doctor in the industry, do you not know that the cost of drugs includes production costs, R&D costs, and sales costs? Why does he dare to publicly mislead the public?

So he is either stupid, he is just purely bad, and is provoking disputes between the public and pharmaceutical companies. This is immoral. Our Novartis will also sue Professor Marit for infringing on our company's reputation."

Wow~~~~

There was another commotion from the reporters at the scene. This was the second international pharmaceutical company to file a lawsuit against Professor Marit. It seemed that Marit was in trouble this time.

Chen Xia and Guerns looked at each other and smiled.

On the next day, the titles were "Who bears the R&D costs of pharmaceutical companies?", "Professor Marite misled the public", "The drug development process revealed", "Does the government pay for the R&D costs?"

OK, the third reversal of public opinion.

It made everyone dizzy, as if Pumpkin Vine Pharmaceutical and Novartis Pharmaceutical were also reasonable.

The report also pointed out that if pharmaceutical companies invest heavily in developing drugs but are deprived of patents and profits, then these pharmaceutical companies will no longer have the motivation to develop new drugs in the future.

How can medical technology be improved in this way? There are so many diseases that humans still endanger everyone's lives and health. At that time, diseases are changing, but everyone does not have the latest medicine to restrain them. Who is the one who suffers?

Do you want money or death?

Well, this is the focus of the controversy in public opinion.

Whether those who are kind-hearted or those who take advantage of the popularity, a large group of celebrities have jumped out, but this time there should be more support for pharmaceutical companies.

For example, a super rich man from a bad country is now suffering from lung cancer and fear of death. He even shouted in the newspaper:

As long as any pharmaceutical company invents a special medicine for treating lung cancer, he is willing to donate $1 billion to the pharmaceutical company that has successfully developed it.

The editor-in-chief of the newspaper probably has received the benefits, and he said this in the "Editor's Comment" of this news:

"Are you willing to face death or are you willing to pay $50 to get a life-saving medicine?"

This remark is directed at what Professor Marit said before that $50 is a representative of the black heart medicine, and after the media packaging, it becomes $50 is a life-saving medicine.

Now, the ball hit Marit's side and the pressure was on his shoulders. Let's see how he dealt with it.

At this level, the whole world is paying attention to this debate. If a person who loses may be ruined.
Chapter completed!